EZSolution™ INF39 | B2530

INF39 is an irreversible and noncytotoxic NLRP3 inhibitor. It inhibits IL-1β release, caspase activation and pyroptosis in THP-1 cells.

INF39 is an irreversible and noncytotoxic NLRP3 inhibitor. It inhibits IL-1β release, caspase activation and pyroptosis in THP-1 cells.

B2530 | EZSolution™ INF39 DataSheet

Alternate Name/Synonyms: INF 39, Ethyl 2-(2-chlorobenzyl)acrylate

Appearance: Liquid

Formulation: A 10 mM ( 5 mg in 2.23 ml) solution in anhydrous DMSO

CAS Number: 866028-26-4

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₁₂H₁₃ClO₂

Molecular Weight: 224.68

Cell-Permeable?: True

Purity: ≥98%

Solubilities:

Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.

Country of Origin: USA

Tag Line: An irreversible NLRP3 inhibitor

MDL Number: MFCD27930542

PubChem CID: 69150705

SMILES: CCOC(=O)C(=C)CC1=CC=CC=C1Cl

InChi: InChI=1S/C12H13ClO2/c1-3-15-12(14)9(2)8-10-6-4-5-7-11(10)13/h4-7H,2-3,8H2,1H3

InChi Key: VTAOWWAFBSFWSG-UHFFFAOYSA-N